Allergic rhinitis
Conditions
Interventions
low-frequency acupuncture combined with fire needle:low-frequency acupuncture combined with fire needle
high-frequency acupuncture:high-frequency acupuncture
Western medicine group:Budesonide Nasal Spray
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for moderate to severe persistent allergic rhinitis; 2. History of moderate to severe persistent allergic rhinitis = 2 years; 3. The total nasal symptom score (TNSS) = 4 points before treatment 1 week ago; 4. The age ranged from 18 to 65 years; 5. Subjects agree to join the study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of chronic sinusitis or chronic sinusitis detected by sinonasal X-ray examination; 2. Patients with organic lesions in nasal cavity or undergoing nasal surgery; 3. Patients with respiratory tract infection or acute sinusitis, or with inflammation on chest X-ray within the past 2 weeks; 4. Patients who had received western medicine or traditional Chinese medicine (TCM) through nasal, oral or systemic route within the past 2 weeks; 5. Patients who had received acupuncture, moxibustion, pot, intranasal Chinese medicine inhalation and other physical therapies within the scope of traditional Chinese medicine and other traditional medicine within the past 2 weeks; 6. Patients who had received specific immunotherapy within the previous year; 7. Women who were pregnant, lactating, or planned to become pregnant during the trial; 8. Patients with severe respiratory system diseases, cardiovascular and cerebrovascular diseases, liver, spleen, kidney and hematopoietic system diseases, mental diseases and infectious diseases; 9. The presence of any contraindications to acupuncture, scarring or infection at the surgical site, or systemic illness at the surgical site considered by the investigator to be inappropriate for intervention; 10. Patients with Hemorrhagic tendency or coagulation dysfunction; 11. Patients identified by the investigator as unable to cooperate with treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total nasal symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total nonnasal symptom score;Total ocular symptom score;Rhinoconjunctivitis quality of life questionnaire;Rhinitis control assessment test;Rescue medication score;Generalized Anxiety Disorder;Patient Health Questionnaire;Duration of response;Number of days of rhinitis onset;Acupuncture expectancy scale;Patient acceptance and satisfaction;Adverse events; | — |
Countries
China
Contacts
Public ContactZhao Jiping
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed